(Competitive Insight/Unsplash) While GLP-1 drugs such as Wegovy and Ozempic are now being broadly championed and widely used, ...

Popular drugs for diabetes and weight loss could have an unexpected side effect. Glucagon-like peptide 1 (GLP-1) receptor agonists, which are used to treat type 2 diabetes and/or obesity, were linked ...

A peer-reviewed analysis of U.S. adverse event data has found that patients taking Wegovy face nearly five times the risk of ...

New research has discovered certain weight-loss medications could be associated with an increased risk of serious eye conditions, and even vision loss. Two studies, published in JAMA, analyzed how ...

LOUISVILLE, Ky. (WKRC) - Patients using popular weight loss medications, such as Ozempic and Wegovy, are being urged to undergo regular eye examinations due to a potential risk of vision loss. Medical ...

Share on Pinterest A commonly prescribed diabetes medication is emerging as a promising treatment for age-related macular degeneration (AMD). George Pachantouris/Getty Images Researchers say the type ...

Share on Pinterest Research on GLP-1 drugs and eye health has been inconsistent, but experts say the risk of serious eye disease is generally low. Getty Images/Hiraman Studies have linked GLP-1 ...

Wegovy may raise the risk of "eye stroke" and vision loss, especially in men, compared to Ozempic due to higher doses of the ...

A small percentage of patients on injectable weight loss drugs such as Ozempic and Wegovy experienced permanent vision loss, according to a new study. The report, published Thursday in the medical ...

A major study links Wegovy to a rare form of sudden vision loss, and finds men may face three times the risk of women.

Ozempic blindness isn’t a real diagnosis. It’s a nickname used to describe sudden vision loss that may be linked to the weight loss drugs semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, ...